Reviewing OBIO's Building Your Early-Stage Strategy Toolbox
On June 26th, OBIO hosted Building Your Early-Stage Strategy Toolbox featuring sessions on formulating a non-dilutive funding strategy, early-stage business strategies, and preparing investor materials.
Engaging with the FDA: An Insider's Perspective - Reviewing Dr. Yuan's Six Considerations
On June 14th, OBIO hosted Dr. Yuan Fang (VP Regulatory Affairs, Quality and Manufacturing; Focal Healthcare Inc.) who spoke about his perspective on the recent changes at the U.S. Food and Drug Administration (FDA).
How to Develop Commercialization Strategies and Be Ready for Anything: Reviewing Dr. Brian Jahns Keynote
During his lively and highly engaging presentation on June 12, ‘Strategic Marketing & Commercialization Plans for Early Stage Companies,’ Dr. Brian Jahns (Senior VP, Commercial and Business Development at Trillium Therapeutics Inc) discussed approaches for developing strategies and the importance of scenario planning.
Medical Device Playbook Recap and Photo Gallery
On May 10, 2018, Medical Device Playbook 2018 Toronto, co-hosted by Starfish Medical and OBIO, drew a standing-room only audience of 170 health science industry professionals, from company executives, to QA, regulatory and R&D engineering experts from start-ups, manufacturers, consultancies, regulatory and academic organizations.
OBIO 2018 Leadership Event Recap and Launch of ‘Use It or Lose It’ Report
On May 3, OBIO welcomed health science leaders, CEOs and the investment community to the tenth annual OBIO Leadership Event, also saw the launch of Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap, OBIO's 2018 Industry Report.